×
About 500 results

ALLMedicine™ Paroxysmal Supraventricular Tachycardia Center

Research & Reviews  94 results

Effectiveness of the modified Valsalva manoeuvre in adults with supraventricular tachyc...
https://doi.org/10.1097/MEJ.0000000000000862
European Journal of Emergency Medicine : Official Journal... Lodewyckx E, Bergs J

Aug 19th, 2021 - Cardiac arrhythmia, specifically paroxysmal supraventricular tachycardia (SVT), accounts for a substantial proportion of emergency medical services resources utilisation. Reconversion requires increasing the atrioventricular node's refractoriness,...

Essentials of Paroxysmal Supraventricular Tachycardia for the Pediatrician.
https://doi.org/10.3928/19382359-20210217-01
Pediatric Annals; Borquez AA, Williams MR

May 27th, 2021 - Paroxysmal supraventricular tachycardia (SVT) is the most common clinical arrhythmia in young patients. With an estimated prevalence of roughly 1 in 500 children, a pediatrician may knowingly or unknowingly see several patients who are affected ea...

Prevalence and incidence of patients with paroxysmal supraventricular tachycardia in th...
https://doi.org/10.1111/jce.15109
Journal of Cardiovascular Electrophysiology; Rehorn M, Sacks NC et. al.

May 25th, 2021 - Paroxysmal supraventricular tachycardia (PSVT) encompasses a range of heart rhythm disorders leading to rapid heart rates. By virtue of its episodic nature, diagnosing PSVT is difficult and estimating incidence and prevalence on a population level...

Projectile vomiting and Valsalva-like abdominal contractions as an uncommon presentatio...
https://doi.org/10.1016/j.jelectrocard.2021.04.010
Journal of Electrocardiology; Paparella R, Mallardo S et. al.

May 7th, 2021 - Paroxysmal supraventricular tachycardia (PSVT) is a prevalent pediatric arrhythmia. Neonatal and infantile-onset presentation is unspecific, thus making differential diagnosis essential in not delaying crucial intervention. We here describe the ca...

Long-Term Outcomes of Near-Zero Radiation Ablation of Paroxysmal Supraventricular Tachy...
https://doi.org/10.1016/j.jacep.2021.02.017
JACC. Clinical Electrophysiology; Bergonti M, Dello Russo A et. al.

May 3rd, 2021 - This study aimed to assess the long-term outcomes of minimally fluoroscopic approach (MFA) compared with conventional fluoroscopic ablation (ConvA) in terms of recurrences of arrhythmia and long-term complications. Catheter ablation (CA) of suprav...

see more →

Drugs  93 results see all →

Clinicaltrials.gov  3 results

Safety Study of Intranasal Etripamil for the Termination of Spontaneous Episodes of Paroxysmal Supraventricular Tachycardia (PSVT). NODE-302
https://clinicaltrials.gov/ct2/show/NCT03635996

Mar 29th, 2021 - The NODE-302 study is an extension of the NODE-301 efficacy study. It is a multi-centre, open label study designed to evaluate the safety of etripamil NS 70 mg when self-administered by patients for spontaneous episodes of PSVT in an outpatient se...

Efficacy and Safety of Intranasal MSP-2017 (Etripamil) for the Conversion of PSVT to Sinus Rhythm
https://clinicaltrials.gov/ct2/show/NCT02296190

Dec 30th, 2020 - This is a multi-center, randomized, double-blind, placebo-controlled, dose-ranging study to evaluate the effects of 4 different doses of MSP-2017 (Etripamil) in subjects with paroxysmal supraventricular tachycardia. It includes an up to 21-day Scr...

Efficacy and Safety of Azimilide for the Treatment of Patients With Atrial Fibrillation
https://clinicaltrials.gov/ct2/show/NCT00035477

Oct 3rd, 2011 - Atrial fibrillation (abnormal rhythm in the upper chamber of the heart) is a common supraventricular arrhythmia (abnormal heart rhythm) for which antiarrhythmic therapy is often prescribed. The primary goals of therapy are to maintain sinus rhythm...

see more →

News  9 results

Nasal Spray Resurrected After Showing Clinical Benefits for PSVT
https://www.medscape.com/viewarticle/951243

May 16th, 2021 - Significant improvement in the control of symptoms related to paroxysmal supraventricular tachycardia (PSVT) is resurrecting etripamil as a self-administered nasal spray a year after it failed to meet the primary endpoint in a phase 3 trial, accor...

Nasal-Spray Calcium-Channel Blocker Promising for Converting Paroxysmal SVT
https://www.medscape.com/viewarticle/899738

Jul 24th, 2018 - Self-treatment of acute paroxysmal supraventricular tachycardia (SVT) with a nasal spray containing a short-acting calcium-channel blocker is likely to be possible with a high rate of conversion to sinus rhythm, suggests a phase 2 study. The nasal...

NODE-1: Simple Nasal Spray May Short-circuit Acute PSVT
https://www.medscape.com/viewarticle/880046

May 16th, 2017 - CHICAGO, IL — A nasal spray containing the calcium-channel blocker etripamil could allow patients to convert acute paroxysmal supraventricular tachycardia (PSVT) outside the hospital, phase 2 data from the Intranasal Etripamil for the Conversion o...

Social Activism Along With Device, Drug Innovations: HRS 2017
https://www.medscape.com/viewarticle/879672

May 8th, 2017 - CHICAGO, IL — The diverse city of Chicago will play host this week to new research on subcutaneous and leadless pacing, atrial fibrillation detection in asymptomatic patients, and the possibility of converting paroxysmal supraventricular tachycard...

ISC: Cryptogenic stroke linked to PSVT in absence of atrial fibrillation
https://www.mdedge.com/neurology/article/107082/stroke/isc-cryptogenic-stroke-linked-psvt-absence-atrial-fibrillation
M. Alexander Otto

Mar 4th, 2016 - LOS ANGELES – Paroxysmal supraventricular tachycardia is associated with subsequent ischemic stroke in patients without documented atrial fibrillation, according to a claims analysis of 42,152 Medicare enrollees at least 66 years old. Atrial fibri.

see more →

Patient Education  1 results see all →